Cost-Effectiveness of Real-World Administration of Concomitant Viscum album L. Therapy for the Treatment of Stage IV Pancreatic Cancer

Table 1

Baseline characteristics of included patients with stage IV mPC.

Variable	All (n = 88)	C (n = 34)	(n = 54)	value
Age, mean, SD	65.60 (11.40)	68.61 (10.06)	63.71 (11.87)	0.04
Gender, female, n (%)	45 (51.1)	17 (50.0)	28 (51.90)	1
Body mass index <18.5, underweight, n (%)	56 (93.3)	20 (90.9)	36 (94.70)	0.97
Comorbidities, yes, n (%)	59 (67.0)	21 (61.8)	38 (70.40)	0.55
Arterial hypertension, n (%)	32 (36.4)	16 (47.1)	16 (29.6)	0.10
Diabetes mellitus type II, n (%)	13 (14.8)	6 (17.6)	7 (13.0)	0.55
Chronic pancreatitis, n (%)	2 (2.3)	2 (5.9)	0	0.15
Pancreatic insufficiency, n (%)	1 (1.1)	1 (2.9)	0	0.39

n, number of patients; %, percent; SD, standard deviation.